Those aiming for above-average market returns often engage in the meticulous process of stock picking. Choosing the right stocks can make a substantial difference in your wealth.
As of close of business last night, Pyxis Oncology Inc’s stock clocked out at $1.10, up 5.77% from its previous closing price of $1.04. In other words, the price has increased by $5.77 from its previous closing price. On the day, 0.54 million shares were traded. PYXS stock price reached its highest trading level at $1.11 during the session, while it also had its lowest trading level at $0.9901.
Ratios:
To gain a deeper understanding of PYXS’s stock, we examine its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 7.49 and its Current Ratio is at 7.49. In the meantime, Its Debt-to-Equity ratio is 0.17 whereas as Long-Term Debt/Eq ratio is at 0.16.
On November 08, 2024, Stephens started tracking the stock assigning a Overweight rating and target price of $13.
On August 08, 2024, Stifel started tracking the stock assigning a Buy rating and target price of $10.Stifel initiated its Buy rating on August 08, 2024, with a $10 target price.
Insider Transactions:
Investing in insider trades can also provide an investor with insight into how management views future stock prices. A recent insider transaction in this stock occurred on Apr 21 ’25 when HUMPHREY RACHEL bought 13,896 shares for $1.03 per share.
HUMPHREY RACHEL bought 200 shares of PYXS for $194 on Apr 17 ’25. On Apr 14 ’25, another insider, HUMPHREY RACHEL, who serves as the Director of the company, bought 1,400 shares for $0.97 each.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, PYXS now has a Market Capitalization of 67749440 and an Enterprise Value of -38981544. For the stock, the TTM Price-to-Sale (P/S) ratio is 4.19 while its Price-to-Book (P/B) ratio in mrq is 0.55. Its current Enterprise Value per Revenue stands at -2.414 whereas that against EBITDA is 0.623.
Stock Price History:
The Beta on a monthly basis for PYXS is 1.15, which has changed by -0.7505669 over the last 52 weeks, in comparison to a change of 0.09969199 over the same period for the S&P500. Over the past 52 weeks, PYXS has reached a high of $5.39, while it has fallen to a 52-week low of $0.83. The 50-Day Moving Average of the stock is 2.13%, while the 200-Day Moving Average is calculated to be -54.41%.
Shares Statistics:
It appears that PYXS traded 580.31K shares on average per day over the past three months and 586240 shares per day over the past ten days. A total of 59.97M shares are outstanding, with a floating share count of 43.77M. Insiders hold about 28.94% of the company’s shares, while institutions hold 39.28% stake in the company. Shares short for PYXS as of 1744675200 were 7131225 with a Short Ratio of 12.29, compared to 1741910400 on 6924016. Therefore, it implies a Short% of Shares Outstanding of 7131225 and a Short% of Float of 13.96.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0
